Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	26.67	111.38	87.93
Graham Fair Price	63.69	2.18	1.33
PEG	-90.22	-0.27	2.72
Price/Book	-9.63	3.03	3.36
Price/Cash Flow	-0.67	59.49	59.89
Prices/Earnings	-68.85	100.77	-323.43
Price/Sales	-12.73	19.63	22.49
Price/FCF	-0.67	59.49	59.89
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.12	0.84	0.84
Operating Margin	-37.83	0.14	0.22
ROA	179.20	< 0.005	< 0.005
ROE	< 0.005	< 0.005	190.07
ROIC	< 0.005	< 0.005	1113.06
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	< 0.005	691.85
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.12	-0.39	216.06
EPS QOQ	-1.19	3.78	218.48
FCF QOQ	0.57	-0.14	-75.43
Revenue QOQ	< 0.005	-0.02	140.32
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-39.24	-41.77	-6.44
Days Sales Outstanding (DSO)	79.96	68.99	-13.72
Inventory Turnover	-2.29	-2.15	6.05
Debt/Capitalization	0.37	0.38	3.48
Quick Ratio	1.27	1.02	-19.61
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.51	5.29	-3.89
Cash	1.38	1.16	-15.58
Capex	-0.02	-0.03	-46.05
Free Cash Flow	0.31	0.27	-12.56
Revenue	0.82	0.82	-0.47
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.35	1.11	-17.67
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.74	15.08	54.84
Naive Interpretation	Member

06 - Financial Health · Bad

Rating